Using Applied Statistics to Study a Pharmaceutical Manufacturing Process by Tiani, John P
Worcester Polytechnic Institute
Digital WPI
Masters Theses (All Theses, All Years) Electronic Theses and Dissertations
2004-04-30
Using Applied Statistics to Study a Pharmaceutical
Manufacturing Process
John P. Tiani
Worcester Polytechnic Institute
Follow this and additional works at: https://digitalcommons.wpi.edu/etd-theses
This thesis is brought to you for free and open access by Digital WPI. It has been accepted for inclusion in Masters Theses (All Theses, All Years) by an
authorized administrator of Digital WPI. For more information, please contact wpi-etd@wpi.edu.
Repository Citation
Tiani, John P., "Using Applied Statistics to Study a Pharmaceutical Manufacturing Process" (2004). Masters Theses (All Theses, All Years).
560.
https://digitalcommons.wpi.edu/etd-theses/560
 i
 
 
 
 
 
Using Applied Statistics to Study a Pharmaceutical Manufacturing Process 
 
by  
 
John Tiani 
 
A Project Report 
 
Submitted to the Faculty 
 
of 
 
WORCESTER POLYTECHNIC INSTITUTE 
 
In partial fulfillment of the requirements for the  
 
Degree of Master of Science 
 
in 
 
Applied Statistics 
 
 
May 2004 
 
 
 
 
 ii
ABSTRACT 
 
The pharmaceutical manufacturing process of interest produces a suspension for 
inhalation.  Currently, the product is manufactured on two lines.  A third and fourth line 
are in the process of being commissioned and plans are currently in place to construct 
three additional lines.  The manufacturing lines operate independently of one another.  
Each manufacturing line consists of two actives compounding tanks so their utilization 
can be rotated to improve manufacturing capacity.   
 
The objective of this project was to study the content uniformity assay values for the 0.25 
mg/mL (0.5 mg) manufacturing process through the application of statistical techniques.  
The study focused on three separate topics: 
 
1. Monitoring process behavior for content uniformity assay values  
2. Ascertaining the equivalence of batches manufactured on Line 1 vs Line 2.   
3. Monitoring the signal to noise ratio of the content uniformity assay values 
 
In order to accomplish the three tasks above, the following statistical techniques were 
applied: 
 
1. Control chart techniques were applied to the data, including standard 
control chart techniques ( x  and S), individuals control chart techniques, 
and modified limits. 
2. An equivalence test for the means of the two processes was conducted. 
3. A new control chart, the SNR chart, was developed and implemented.  
 
The results/conclusions of the application of statistical techniques were:  
 
1. The content uniformity assay values were in statistical process control 
with respect to modified limit control chart techniques.  
2. The Line 1 and 2 data were statistically equivalent.   
3. The quantity ( n x  / s) was in statistical process control.  The SNR 
control chart displayed superior performance to the Individuals control 
chart.   
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1. Introduction 
 
The quality of health care is very important to any society.  Patients and their families 
need and expect high-quality health care.  One does not like to think that a physician's 
diagnosis may be wrong, that a hospital chart is inaccurate, or that a treatment mix-up 
may have occurred.  The drug obtained from the pharmacy is expected to cure the 
infection or relieve the pain and have its intended effect.  People expect that the bottle of 
medicine has the specified number of tablets and that each tablet contains the specified 
quantity of the correct drug. 
 
Law requires quality control in the pharmaceutical industry.  The organization of the 
quality control unit, its responsibilities, and the way it performs its duties are covered by 
federal regulations. The regulations tend to outline a quality control function that 
emphasizes inspection and defect detection, and pharmaceutical quality control 
technology.  In today's pharmaceutical companies, people in all parts of the organization 
are being empowered with increased responsibility and authority for the quality of the 
products and services delivered to internal and external customers.  It is not left solely to 
the quality control department to act as "policemen" to catch the defects.  In today's 
environment, quality of products and services are of concern in all parts of the 
organization.  Quality is introduced in product design, process development, distribution, 
sales, and marketing, rather than in the production component alone.  
 
Chemical and Biological Considerations in Drug Product 
 
The features of a drug product that are the easiest to understand, measure, and control 
tend to fall under the classification of chemical or physical attributes.  For example, the 
amount of active ingredient, the type and amount of excipient, the amount of impurity, 
the time it takes for a tablet or capsule to dissolve, the rate and duration of drug release 
from an extended release formulation, can be measured.  In addition, the stability 
characteristics of a drug product throughout the manufacturing process and up until 
patient use can be monitored. 
 
The quality characteristics of most interest to the patient are: "Does the drug work?" and 
“Is it safe to use?”  These issues are addressed by performing large scale experiments 
called controlled clinical trials, where the efficacy and safety of the drug are carefully 
studied and documented in a large number of patients.  Concurrently, the chemical and 
physical properties of the drug are determined and specified.  Therefore, if the 
manufacturer produces a uniform drug product that is equivalent to the one proven to 
work in clinical trials, the patient's expectation that the drug will work is reasonable. 
 
Although it is not possible for the manufacturer to guarantee the patient that a specific 
tablet, capsule, or injection will cure the ill, the manufacturer can assure the patient that 
the dosage unit was produced by a controlled process that yields units satisfying the same 
chemical and physical specifications as dosage units shown experimentally to be 
bioavailable and therapeutically effective (C. Ralph Buncher and Jia-Yeong Tsay 1994). 
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The Role of the United States Pharmacopoeia (USP) in Assuring Quality 
 
Marketed pharmaceutical products are subject to recognized standards of identity, 
quality, strength, and purity documented in various compendia around the world.  Some 
examples include the United States Pharmacopoeia (USP) and National Formulary, the 
British Pharmacopoeia, the European Pharmacopoeia, the Japanese Pharmacopoeia, and 
the International Pharmacopoeia.  
 
The USP contains standards for drugs and pharmaceutical substances, which are called 
Official Monographs.  In addition, the USP also contains sections called General Tests 
and Assays and General Information.  These sections cover analytical methods, the 
design and analysis of biological assays, as well as general information on how to clean 
glassware, the laws and regulations governing drug manufacturing and distribution, 
stability considerations, validation of compendial methods, and sterility. 
 
The standards published in the USP are recognized as official and required by law in the 
United States under a set of regulations called the Food, Drug, and Cosmetic Act.  These 
standards apply at any time in the life of a drug from production to consumption. 
Manufacturers are expected to develop and utilize release tests and specifications that 
assure that a drug will comply with compendial standards until its expiration date when 
stored as directed (C. Ralph Buncher and Jia-Yeong Tsay 1994). 
 
The Role of the Food and Drug Administration (FDA) in Assuring Quality 
 
The FDA is the federal agency which oversees the quality of drugs discovered, 
developed, and produced for use in the United States.  Other countries around the world 
have similar agencies.  It is through the FDA and similar agencies worldwide that the 
patient and physician have input in the quality control of pharmaceutical products.  
The regulations which guide the FDA and the pharmaceutical industry in the 
manufacturing process are the Current Good Manufacturing Practices (cGMPs), 
published in the Federal Register and in the USP.  The FDA, through its field offices 
around the country, enforces the cGMP regulations through plant inspections, audits, and 
sample analyses.  
  
In order to meet the increasing demands of the FDA, Quality Assurance Departments 
have been expanded.   In most pharmaceutical companies, Validation Departments have 
been created to directly deal with increasing FDA demands for documented proof of 
process quality. With resources at a minimum in most companies, new ways of showing 
and presenting data had to be developed and implemented.  The need to present 
documented proof of quality processes over time has lead to an increased reliance on 
statistical techniques to show that a particular process is in control.  
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1.1. Process Description 
Due to the competitive nature of the pharmaceutical industry and the intellectual property 
at stake, the details of the production process have been omitted for confidentiality 
reasons. 
The product of interest is a New Drug Application (NDA) approved product which is 
currently aseptically manufactured and filled and then packaged at the subject 
pharmaceutical company.  The drug is manufactured at two strengths (0.125 mg/mL and 
0.25 mg/mL), however, the 0.25 mg/mL (0.5 mg) manufacturing process was the focus of 
this study.  This product is the first suspension product to be approved for manufacturing 
at the site and is the only one of its kind approved for use in its intended market.   
The Manufacturing Area consists of two filling lines, one Buffer Preparation Room 
(consisting of 2 buffer preparation tanks which support both Actives Compounding 
Rooms), two Actives Compounding Rooms (#1 and #2), and two Isolator Rooms (#1 and 
#2).  Each Actives Compounding Room (consists of 2 compounding tanks) and each 
Isolator Room (equipped with a processing isolator) supports one filling line.  Either of 
the buffer tanks in the Buffer Preparation Room can be utilized during the manufacturing 
of BIS.  In addition, either of the compounding tanks in the Actives Compounding Room 
can be utilized during the manufacturing of the product.   
The suspension consists of the active ingredient and a number of inactive ingredients.  
The pH of the suspension is buffered and the final product is protected from light and 
moisture loss by an aluminum foil envelope to maximize stability.  The suspension is 
filled into single dose units made of low density polyethylene (LDPE).  Each single dose 
unit contains 2 mL of suspension.  A strip of five single dose units is packed into an 
aluminum foil envelope, for protection from light and moisture loss. 
Primary Packaging  
The primary packaging for all units consists of a LDPE primary container formed from a 
plastic resin.  The microbiological quality of the suspension is maintained by the LDPE 
used in the Blow-Fill-Seal manufacturing process.  The container is translucent and 
allows visual inspection of the suspension which is important for assurance that the 
product is properly resuspended prior to dispensing. Since the foil package protects the 
units from moisture loss and light it is considered part of the primary packaging system.  
The package insert recommends that the patient retain the foil package so that unused 
product can be properly stored. 
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1.2. Problem Statement 
 
The pharmaceutical manufacturing company  received approval to manufacture two 
strengths (0.125 mg/mL and 0.25 mg/mL) of drug product.  This product is the first 
suspension product to be approved for manufacturing at the site.  Currently, the product is 
manufactured on two lines.  A third and fourth line are in the process of being 
commissioned and plans are currently in place to construct three additional lines.  The 
manufacturing lines operate independently of one another.  Each manufacturing line 
consists of two actives compounding tanks so their utilization can be rotated to improve 
manufacturing capacity.  
 
Production on Line 1 started in the beginning of 2000 and production on Line 2 started in 
the beginning of 2001.  At least 100 batches of each concentration have been 
manufactured on both lines.  The company would like to use statistical techniques to 
study the manufacturing process for Lines 1 and 2 during the year 2001 by analyzing the 
content uniformity assay values for the 0.25 mg/mL (or 0.5 mg) manufacturing process.  
The analysis began in 2001 to allow the process to reach steady state.  The study focused 
on three separate topics: 
 
1.2.1. Developing control charts to assess whether or not the process for content 
uniformity assay values was in statistical control 
1.2.2. Developing a statistical equivalence test to compare the means of assay 
values of batches manufactured on Line 1 vs Line 2. 
1.2.3. Developing a control chart to monitor the signal to noise ratio of the 
content uniformity assay values. 
 
1.3. Significance of Problem 
 
The above study is very important to the pharmaceutical company.  The product is the 
only one approved for use in its intended market in the U.S. and therefore, it is critical for 
the company to be able to continue to supply high quality product.  It is critical that the 
company understand its sampling processes and their ability to detect when any of those 
processes is out of control.   
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2. Control Charts For Content Uniformity Assay Values 
 
2.1. Objective 
 
The objective of this analysis was to assess the statistical control of the process for the 
content uniformity assay values.  Based on process experience and knowledge, no 
distinction was made in the active ingredient assay data between the two actives 
compounding tanks for each line. 
 
2.2. Data 
 
Active ingredient assay data (0.5 mg) for individual units (used to determine content 
uniformity) produced on Lines 1 and 2 were collected for the year 2001.  At least 45 
batches were produced on each line during this time period.  Although production on 
Line 1 started in the beginning of 2000 and production on Line 2 started in the beginning 
of 2001, the data analysis focused on the year 2001 to allow the process to reach steady 
state.       
 
Content uniformity testing is reported in the batch record as 10 individual active 
ingredient content values.  Samples are taken throughout the batch (4 from the beginning, 
3 from the middle, and 3 from the end of fill). 
 
2.3. Procedure 
 
After examining the data for spurious or missing values, we conducted the Box-Pierce 
test for autocorrelation on the average of the 10 values for each batch.  This test failed to 
reject the null hypothesis of no autocorrelation at the 5% level for any of the data sets 
considered.  We concluded that the use of control charts for uncorrelated data was 
justified. 
 
Prior to constructing the control charts, an analysis of the begin, middle, and end samples 
was conducted to see if there was a statistically significant difference between the 
locations where the samples were taken.  In order to check the location factor, a PROC 
MIXED procedure in SAS was conducted.  The following model was utilized for the 
analysis: 
 
Y = Xβ + Zγ + ε, 
 
where Y represents a vector of observed data, β is an unknown vector of fixed-effects 
parameters with known design matrix X, γ is an unknown vector of random-effects 
parameters with known design matrix Z, and ε is an unknown random error vector. 
 
For this analysis, the fixed effect was the location of the sample (begin, middle, and end) 
and the random effect was the batch from which the sample was taken.  The analysis 
indicated that there was not a statistically significant difference between the locations 
(begin, middle, and end) at the α = 0.05 level. 
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2.4. Analysis  
 
2.4.1. Correlation Analysis 
 
An autocorrelation analysis was performed for the Line 1 Content Uniformity (CU) data 
from 2001.  The time series plot below represents averages of 10 assay values (4 begin, 3 
middle, and 3 end).  Based on the Box-Pierce Test for autocorrelation, we cannot reject 
the hypothesis that the autocorrelation is 0 (p = 0.86).  In addition, the time series plot 
below appears to be stationary.   
 
Figure 2.4.1-1: Time Series Plot of Line 1 CU Data from 2001 
Time Series Plot for ave10L1y1
av
e1
0L
1y
1
0 10 20 30 40 50
0.23
0.24
0.25
0.26
 
Box-Pierce Test
---------------
     Test based on first 16 autocorrelations
     Large sample test statistic = 10.1872
     P-value = 0.856669  
 
 
 
An autocorrelation analysis was performed for the Line 1 Content Uniformity (CU) data 
from 2001.  The time series plot below represents averages of 10 assay values (4 begin, 3 
middle, and 3 end).  Based on the Box-Pierce Test for autocorrelation, we cannot reject 
the hypothesis that the autocorrelation is 0 (p = 0.73).   In addition, the time series plot 
below appears to be stationary.   
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Figure 2.4.1-2: Time Series Plot of Line 2 CU Data from 2001  
Time Series Plot for ave10L2y1
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Box-Pierce Test
---------------
     Test based on first 24 autocorrelations
     Large sample test statistic = 19.4028
     P-value = 0.730183  
 
 
2.4.2. Location Effect Analysis 
 
For this analysis, there were three levels of the fixed effect “location” and 149 levels of 
the random effect “batch”.  For the location effect, 1 = beginning, 2 = middle, and 3 = 
end. 
 
The location effect was not statistically significant at the α = 0.05 level (prob > F = 
0.1464).   
 
Since there was not a statistically significant difference between the beginning, middle, 
and end of a batch, the data analysis that was conducted in Sections 3 and 4 did not 
distinguish between different portions of the batch.   
 
The results of the analysis are detailed below.   
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Figure 2.4.2-1: SAS PROC MIXED Results for the Line 1 and 2 CU Data from 2001 
 
Tests of Fixed Effects 
 
Source      NDF   DDF  Type III F  Pr > F 
 
LOC           2   294        1.93  0.1464 
 
 
Least Squares Means 
 
Effect  LOC       LSMEAN     Std Error    DF       t  Pr > |t|  Alpha     Lower     Upper 
 
LOC     1     0.24806318    0.00059193   294  419.08    0.0001   0.05    0.2469    0.2492 
LOC     2     0.24694932    0.00067008   294  368.54    0.0001   0.05    0.2456    0.2483 
LOC     3     0.24641532    0.00067008   294  367.74    0.0001   0.05    0.2451    0.2477 
 
 
Differences of Least Squares Means 
 
Effect  LOC  _LOC   Difference    Std Error    DF       t  Pr > |t|  Adjustment     Adj P 
 
LOC     1    2     0.00111385    0.00086752   294    1.28    0.2002  Tukey-Kramer  0.4054 
LOC     1    3     0.00164786    0.00086752   294    1.90    0.0585  Tukey-Kramer  0.1406 
LOC     2    3     0.00053401    0.00092262   294    0.58    0.5632  Tukey-Kramer  0.8316 
 
 
Differences of Least Squares Means 
 
Alpha     Lower     Upper   Adj Low   Adj Upp 
 
0.05   -0.0006    0.0028   -0.0009    0.0032 
0.05   -0.0001    0.0034   -0.0004    0.0037 
0.05   -0.0013    0.0023   -0.0016    0.0027  
 
 
                            
  
2.4.3. x and S Control Charts 
 
x  and S control charts are designed to assess whether subgrouped data come from a 
process which is in a state of statistical control.  These control charts are constructed 
under the assumption that the data come from a normal distribution.   
 
Below are the traditional x  and S control charts for the uncorrelated Line 1 year 2001 
content uniformity (CU) data, using batches as groups each containing ten observations.  
The charts were based on ± 3.29σ limits (0.0005 two-sided or 0.001 one-sided). 
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Figure 2.4.3-1: x Chart of the Line 1 Begin CU Data from 2001 
X-bar Chart for L1y1
Subgroup
X
-b
ar
CTR = 0.247
UCL = 0.249
LCL = 0.244
0 10 20 30 40 50
0.235
0.245
0.255
 
 
In the x chart in Figure 2.4.3-1, 20 of the 49 points are beyond the control limits.  
Specifically, the process means go well outside the limits on four occasions, twice above 
and twice below.  Many other means are close to the limits, both outside and inside. A 
possible explanation for the out of control signals is the result of mixing (addressed in 
more detail at the end of the section).  The out of control points appear to be random with 
no systematic pattern. 
 
Figure 2.4.3-2: S Chart of the Line 1 Begin CU Data from 2001 
S Chart for L1y1
0 10 20 30 40 50
Subgroup
0
2
4
6
8
10
12
(X 0.001)
S
CTR = 0.002
UCL = 0.004
LCL = 0.000
 
 
In the S chart in Figure 2.4.3-2, 8 of the 49 points are beyond the control limits.  
Specifically, the process standard deviations go well outside the limits on three occasions 
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(one value is much larger than the others).  Most other standard deviations are very low.   
The out of control points appear to be random with no systematic pattern. 
 
Figure 2.4.3-3: x Chart of the Line 2 CU Data from 2001 
X-bar Chart for L2y1
Subgroup
X
-b
ar
CTR = 0.247
UCL = 0.249
LCL = 0.245
0 20 40 60 80 100 120
0.235
0.245
0.255
 
 
In the x chart in Figure 2.4.3-3, 20 of the 101 points are beyond the control limits.  
Specifically, the process means go well outside the limits on one occasion (above).  Many 
other means are close to the limits, both outside and inside. A possible explanation for the 
out of control signals is the result of mixing (addressed in more detail at the end of the 
section).  The out of control points appear to be random with no systematic pattern. 
 
Figure 2.4.3-4: S Chart of the Line 2 CU Data from 2001 
S Chart for L2y1
Subgroup
S
CTR = 0.002
UCL = 0.003
LCL = 0.000
0 20 40 60 80 100 120
0
2
4
6
8
(X 0.001)
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In the S chart in Figure 2.4.3-4, 13 of the 101 points are beyond the control limits.  
Specifically, the process standard deviations go well outside the limits on seven 
occasions (two values are much larger than the others).  Most other standard deviations 
are very low.  The out of control points appear to be random with no systematic pattern. 
 
The x  and S control charts indicate that the Line 1 and 2 processes in 2001 were not in 
statistical control.  The patterns that are shown on the x  charts may be symptomatic of 
mixing.  Since there are 10 independent filling needles on the Blow-Fill-Seal Machine 
and samples of 4 (begin), 3 (middle), and 3 (end) are randomly collected for each batch, 
the performance of a specific filling needle is not being consistently represented.  This 
phenomenon could be a subject for future study.  Unfortunately, this issue could not be 
addressed appropriately in this document since the author did not have ownership of the 
process. 
 
2.4.4. Individual Measurement Control Charts 
 
The x  and S control charts indicated that the Line 1 and 2 processes in 2001 were not in 
statistical control.  The fact that between-batch variation was large relative to within-
batch variation, and that the units were filled on multiple nozzles suggested that mixing 
was at least partly to blame for the poor patterns observed on the x charts.  Since there 
was no record of which nozzles filled which of the tested units, a more appropriate 
method was sought for charting the process level.  By eliminating within-batch variation 
as the measure of the size of between-batch variation, Individual Measurement Control 
Charts provide an alternative, and perhaps, fairer measure of process control. The X 
individual control charts are constructed under the assumption that the data are 
uncorrelated (previously verified in Section 2.4.1) and normally distributed (verified in 
this section).  The charts were created by treating each batch as a single observation (e.g. 
the content uniformity values from begin, middle, and end portions of each batch were 
averaged to obtain one data point).  The control procedure uses the moving range of two 
successive observations to estimate the process variability.  The moving range (MR) is 
defined as MRi = 1−− ii xx  (Douglas C. Montgomery 1996). 
 
Below are the X individual control charts and MR(2) control charts for the uncorrelated 
Line 1 year 2001 content uniformity (CU) data.  The charts were based on ± 3.29σ limits 
(0.0005 two-sided or 0.001 one-sided).   
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Figure 2.4.4-1: Normal Probability Plot for the Line 1 CU Data from 2001 
 
Normal Probability Plot for ave10L1y1
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The normal probability plot indicates that normality is a reasonable assumption for these 
data.  Based on the Shapiro-Wilks Test for normality, we cannot reject the hypothesis that 
the data comes from a normal distribution (p = 0.64).   
Figure 2.4.4-2: X Individual Chart for the Line 1 CU Data from 2001 
 
X Chart for ave10L1y1
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In the X Individuals Chart in Figure 2.4.4-2, 2 of the 49 points are slightly beyond the 
control limits.  Specifically, the process means are mostly situated along the center line.  
Very few points are close to the control limits. 
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Figure 2.4.4-3: MR(2) Individual Chart for the Line 1 CU Data from 2001 
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In the MR(2) chart in Figure 2.4.4-3, 2 of the 49 points are beyond the control limits.  
One point is slightly beyond and one point is far beyond the upper control limit.  
Specifically, the moving ranges are mostly situated along or below the center line.  Very 
few points are close to the control limits. 
 
Figure 2.4.4-4: Normal Probability Plot for the Line 2 CU Data from 2001 
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The normal probability plot indicates that normality is a reasonable assumption for these 
data.  Based on the Shapiro-Wilks Test for normality, we cannot reject the hypothesis that 
the data comes from a normal distribution (p = 0.59).   
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Figure 2.4.4-5: X Individual Chart for the Line 2 CU Data from 2001 
X Chart for ave10L2y1
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In the X Individuals Chart in Figure 2.4.4-5, 1 of the 101 points is slightly beyond the 
control limits.  Specifically, the process means are mostly situated along the center line.  
Very few points are close to the control limits. 
 
Figure 2.4.4-6: MR(2) Individual Chart for the Line 2 CU Data from 2001 
MR(2) Chart for ave10L2y1
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In the MR(2) chart in Figure 2.4.4-6, 0 of the 49 points are beyond the control limits.  
Specifically, the moving ranges are mostly situated along or below the center line.  One 
point is fairly close to the upper control limit.     
 
Although the X and MR(2) individual control charts have wider limits and only a few 
points were outside the limits on the various charts, these control charts reaffirm that the 
Line 1 and 2 processes in 2001 were not in statistical control. 
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2.4.5. Modified Control Limits 
 
Despite the fact that traditional x  and S control charts and Individual Measurement 
control charts indicated that the Line 1 and 2 processes in 2001 were not in statistical 
control, the natural variability of the processes is much smaller than the range of the 
specification limits. 0.237 – 0.262 mg/mL.  In such situations, Modified Control Charts 
are appropriate for process monitoring if some drift in the process mean is acceptable.  
The modified control charts are constructed under the assumption that the data are 
uncorrelated and normally distributed.  The modified x  control chart is concerned only 
with detecting whether the true process mean µ is located such that the process is 
producing a fraction non-conforming in excess of some specified value δ.  In practice, µ 
is allowed to vary over an interval µL ≤ µ ≤ µU, whose endpoints are chosen as the 
smallest and largest permissible values of µ, consistent with producing a fraction non-
conforming of at most δ (Douglas C. Montgomery 1996). 
 
For consistency with the previously displayed control charts ( x  and S charts and X 
Individuals charts), the modified control limits were based on ± 3.29σ limits (0.0005 two-
sided or 0.001 one-sided).  The control limits were derived with the following formula: 
 
UCL = USL – (zδ – 3.29/n^1/2)σ and LCL = LSL + (zδ – 3.29/n^1/2)σ, 
 
Where δ = 0.01 (process fraction non-conforming), 
z = 2.33, 
n = subgroup size,  
σ = process standard deviation 
 
Below are the results obtained by applying modified control limits to the content 
uniformity Line 1 and 2 data for 2001.  
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Figure 2.4.5-1: Modified x  Chart for the Line 1 CU Data from 2001 
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In the Modified x  chart in Figure 2.4.5-1, none of the 49 points are beyond the control 
limits.  Specifically, the process means are mostly situated along or below the center line.  
Very few points are close to the control limits.  There is one point which is very close to 
the lower control limit. 
 
Figure 2.4.5-2: Modified x  Chart for the Line 2 CU Data from 2001 
X Chart for ave10L2y1
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In the Modified x  chart in Figure 2.4.5-2, 0 of the 101 points are beyond the control 
limits.  Specifically, the process means are mostly situated along or below the center line.  
No points are close to the control limits.     
 
 17
The Line 1 and 2 processes in 2001 were in statistical control with respect to the modified 
x  control charts. 
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3. Equivalence Testing 
 
3.1. Objective 
 
The objective of this analysis was to show statistical equivalence between the means of 
active ingredient assay values of batches manufactured on Line 1 and Line 2.  No 
distinction was made in the active ingredient assay data between the two actives 
compounding tanks for each line.  Based on the results of the PROC MIXED SAS 
procedure in Section 2.4.2, the location was not factored into the analysis. 
 
3.2. Data 
 
Active ingredient assay data for individual units (used to determine content uniformity) 
from the year 2001 on Lines 1 and 2 were collected.   
 
Content uniformity testing is reported in the batch record as 10 individual active 
ingredient content values.   
 
3.3. Procedure (Bolton 1990) 
 
In order to compare the active ingredient assay data from Lines 1 and 2, an equivalence 
study was conducted using the following steps:   
 
1) Calculate summary statistics of the batches manufactured in 2001 for Line 1 (L1) and 
Line 2 (L2).  Use these as estimates for the mean ( x ) and standard deviation (s). 
2) Display data graphically to get an idea of the distribution.  Verify the assumption of 
normally distributed data. 
3) Select α, the probability of committing a type I error (rejecting a true null hypothesis, 
claim the lines have equivalent active ingredient assay values when they do not) for 
the study. 
4) Select β, the probability of committing a type II error (failing to reject a false null 
hypothesis, claim the lines do not have equivalent active ingredient assay values 
when they do) for the study. 
5) Select δ, the equivalence margin, for the study. 
6) Calculate the sample size required (per group) to achieve the desired level of power 
for the study.  For an equivalence study (based on a two-sided 100 x (1-2α)% 
confidence interval), the sample size required per group (n1 = n2) is: 
 
n2 = 2[(Z1-α + Z1-β/2)(s/δ)]2 
 
Power: 1 – β = 2 Φ[δ(2s2/n2)-1/2 – Z1-α]- 1, 
 
when µ1 = µ2. 
 
 
 19
7) Calculate the two-sided 100 x (1-2α)% confidence interval for µ1 – µ2 (since the 
population variances are unknown and sample sizes are large): 
 
2
2
2
1
2
1
121 )( n
s
n
szxx +±− −α  
 
 
8) Conclude equivalence if the two-sided 100 x (1-2α)% confidence interval for µ1 – µ2, 
[Cµ1, Cµ2] is in  [-δ, δ] or [-δ < Cµ1 < Cµ2 < δ], where Cµ1 and Cµ2 are the lower and 
upper limits of the confidence interval, respectively. 
 
 
3.4. Analysis  
 
Content uniformity data from 0.5 mg strength production batches manufactured during 
2001 were used for the analysis since the process was in statistical control during this 
time period.  These values were most representative of individual units as the values were 
not averaged.  Content uniformity testing is reported in the batch record as individual 
active ingredient content values to 4 decimal places.     
 
 
3.4.1. Equivalence Study:  Lines 1 and 2 
 
Table 3.4.1-1:  Summary Statistics for Line 1 and 2 CU Data from 2001 
 
Summary Statistics
                    L1y1                L2y1                
------------------------------------------------------------
Count               490                 1010                
Average             0.246572            0.247025            
Median              0.24665             0.2469              
Variance            0.0000173501        0.0000080143        
Standard deviation  0.00416534          0.00283095          
Standard error      0.000188171         0.0000890784        
Minimum             0.2258              0.2286              
Maximum             0.2603              0.264               
Range               0.0345              0.0354              
------------------------------------------------------------  
 
An α value = 0.05, which is the probability of committing a type I error, was selected for 
the study.  A δ value = 0.0015, which is the equivalence margin, was selected for the 
study. 
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Based on the summary statistics, the two-sided 100 x (1-2α)% confidence interval for µ1 
= µ2 (assuming population variance is known) where, 
 
µ1 = mean of Line 1  
µ2 = mean of Line 2 
 
was calculated using the following formula: 
 
2
2
2
1
2
1
121 )( n
s
n
szxx +±− −α  
 
 
 
The resulting confidence interval for the difference in the content uniformity means is (-
0.0014, 0.0006).  Since (-0.0014, 0.0006) is in the interval (-0.0015, 0.0015), equivalence 
of the means is concluded. 
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4. Control Charts For SNR Values of the Content Uniformity 
Assay Data 
 
4.1. Objective 
 
The objective of this analysis was to establish control charts for the signal-noise ratio 
(SNR) values of the content uniformity assay data.  Distinction was made in the active 
ingredient assay data between the two actives compounding tanks for each line.  Normal 
practice at company is to calculate the relative standard deviation, s/ x  (specification is 
NMT 6.0%) for the content uniformity data since this statistical acceptance criterion is 
referenced in the USP.  Rather than looking at the relative standard deviation, for this 
project, its reciprocal, the SNR ( x  / s) was analyzed since this quantity has a more 
desirable distribution (non-central t).  Although SNR values may be charted by 
Individuals Measurement charts, a new control chart, which we call the SNR Chart, was 
developed specifically to monitor SNR data.  No description of the SNR Chart has been 
located in related literature. 
 
4.2. Data 
 
Content uniformity testing is currently reported in the batch record as 10 individual active 
ingredient content values (4 begin, 3 middle, and 3 end samples).  
 
The analysis detailed below focused on batch production data for Line 2 during the 
beginning of 2001 where 4 begin, 3 middle, and 3 end content uniformity values were 
reported in the batch records.  For each group of 10 content uniformity values, the 
relative standard deviation (s / x ) is calculated.  Since the location effect analysis in 
Section 2.4.2 determined that there was not statistical difference between the begin, 
middle, and end content uniformity data, the data was combined for the analysis.  
 
4.3. Procedure 
 
The SNR n ( x  / s) was assumed to be non-centrally t distributed based on the 
following: 
 
x  ~ ),(
2
n
N σµ  
 
and 
 
2
2)1(
σ
sn −  ~ 2 1−nχ   
 
therefore, 
 
 22
n
s
x  ~ n
1
),(
2
1
2
−
−
n
n
N
nχσ
σµ
 ~ 
1
)1,(
2
1
−
−
n
N
nχ
δ  ~ tn-1,δ    where   
 
t is the non-central t distribution with n-1 degrees of freedom, 
 and δ is the non-centrality parameter, δ = σ
µn  
 
An interesting property of the SNR is that the process may change in such a way that the 
value of δ remains unchanged.  Therefore, while changes in δ imply changes in the 
process, changes in level and spread in the original measurements do not necessarily 
translate into changes in the distribution of the SNR. 
 
The non-central t distribution has two parameters (Evans et al., 1993): the degrees of 
freedom, f (a positive integer), and the non-centrality parameter, δ (a real number). It is 
denoted by t: f, δ. Its probability density function (p.d.f.) (Lehmann, 1959) can be 
expressed as: 
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Its rth moment about the origin is: 
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To simplify the notation, let 
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f
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Using these formulae, we can write the mean ),( δµ f , variance ),(2 δσ f , and 
coefficient of skewness ),(3 δη f of the t: f, δ distribution as:  
 
 
δδµ )(
2
),( fgff =    (f > 1),             (1) 
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Three different methods for estimating the non-centrality parameter δ were considered 
First, δ was estimated using equation (1) and the mean of the signal to noise ratio values 
( SNRx ). 
 
 
δˆ  =  
2
)( ffg
nxSNR    (3) 
 
Second, δ was estimated using equation (2) and the variance of the signal to noise ratio 
values (s2SNR). 
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Third, the non-centrality parameter (δ) was estimated using the following equation:  
 
δˆ  =  
s
nx  ,       (5) 
 
where  
 
x  is the mean of the batch means and  
s   is the mean of the batch standard deviations. 
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4.4. Determining the Best Method for Estimating the Non-centrality Parameter 
 
In order to ascertain the best of these three estimation methods, a small simulation study 
was conducted. The SAS macro simulation detailed in Appendix 1 was used to simulate 
subsets of data from a normal distribution.   
 
Since data analysis will involve the first 25 batches manufactured during the year 2001 
for Line #2 (Tanks V-211 and V-212) and 10 data points from each batch will be 
analyzed, the SAS macro simulation was run to create 1000 data sets, each consisting of 
25 samples of size of 10. The mean was taken to be 0.248 and standard deviation to be 
0.003, the values for the actual data from Line #2. 
 
For each data set, each of the 3 different methods given in (3)-(5) was used to estimate 
the non-centrality parameter δ, which in turn was used to calculate the level 0.001 critical 
value of the non-central t distribution.  The ( n x  / s) values were then compared to the 
level 0.001 critical values to obtain false-alarm rates.  Tables 4.4-1 – 4.4-3 show the 
results of three runs of the simulation.  Delta1, Delta2, and Delta3 refer to non-centrality 
parameter estimates calculated from equations (3), (4), and (5), respectively. 
 
Table 4.4-1:  Results from Simulation #1 
 0.001 Critical 
Value 
# of Minimum Values 
Below 0.001 Critical Value n
ppp )
ˆ1(ˆ96.1ˆ −±  
Delta 1 148.4 24 (0.015, 0.033) 
Delta 2 144.3 13 (0.006, 0.020) 
Delta 3 148.8 25 (0.015, 0.035) 
 
Table 4.4-2:  Results from Simulation #2 
 0.001 Critical 
Value 
# of Minimum Values 
Below 0.001 Critical Value n
ppp )
ˆ1(ˆ96.1ˆ −±  
Delta 1 148.7 20 (0.011, 0.029) 
Delta 2 144.9 11 (0.005, 0.017) 
Delta 3 149.1 20 (0.011, 0.029) 
 
Table 4.4-3:  Results from Simulation #3 
 0.001 Critical 
Value 
# of Minimum Values 
Below 0.001 Critical Value n
ppp )
ˆ1(ˆ96.1ˆ −±  
Delta 1 148.4 20 (0.011, 0.029) 
Delta 2 144.5 11 (0.005, 0.017) 
Delta 3 148.9 25 (0.015, 0.035) 
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The expected number of values below the critical value would be 25 since 1000 sets of 25 
were compared to the 0.001 critical value of the non-central t distribution. 
 
After comparing the results from the 3 simulations, Delta2 appears clearly inferior to 
either Delta1 or Delta3.  Of the remaining two, Delta3 performed marginally better. 
Therefore, Delta3 was used to estimate δ in all subsequent calculations.  
 
4.5. Analysis of SNR Data 
 
4.5.1. Tank V-211 
 
Begin, middle, and end data from the first 25 batches manufactured during the year 2001 
for Line #2 (Tank V-211) were analyzed.  For each group of 10 content uniformity values 
from a single batch, the quantity SNR= ( n x  / s) was calculated.  The summary 
statistics for the SNR values are detailed below: 
 
Table 4.5.1-1:  Summary Statistics – Tank V-211 SNR Values in 2001 
Summary Statistics for v211bmey01snrn
Count = 25
Average = 590.277
Median = 575.256
Mode = 
Geometric mean = 572.288
Variance = 22320.5
Standard deviation = 149.4
Standard error = 29.8801
Minimum = 319.399
Maximum = 928.657
Range = 609.258
Lower quartile = 499.389
Upper quartile = 635.998
Interquartile range = 136.61
Skewness = 0.549081
Stnd. skewness = 1.12081
Kurtosis = 0.444296
Stnd. kurtosis = 0.453458
Coeff. of variation = 25.3102%
Sum = 14756.9  
 
 
Percentiles for v211bmey01snrn
1.0% = 319.399
5.0% = 337.91
10.0% = 440.081
25.0% = 499.389
50.0% = 575.256
75.0% = 635.998
90.0% = 832.105
95.0% = 889.214
99.0% = 928.657  
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Figure 4.5.1-1: Box and Whisker Plot for Tank V-211 SNR Values in 2001 
Box-and-Whisker Plot
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Figure 4.5.1-2: Histogram for Tank V-211 SNR Values in 2001 
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Figure 4.5.1-3: Normal Probability Plot for Tank V-211 SNR Values in 2001 
Normal Probability Plot for v211bmey01snrn
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The normal probability plot of the data below indicates non-normality (as expected). 
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Delta3 was used to calculate the 0.001 critical value (δ = 554.2, 9 degrees of freedom) of 
314.9 for the SNR chart displayed in Figure 4.5.1-4.  
  
Figure 4.5.1-4: SNR Chart for Tank V-211 SNR Values in 2001 
X Chart for V211bmey01snrn
0
200
400
600
800
1000
0 5 10 15 20 25 30
Observation
n^
0.
5 
x 
SN
R
Data
LCL
 
 
All SNR values were above the one-sided lower control limit (level 0.001 critical value = 
314.9) indicating that the process is in control.  Values ranged from 319 to 929. 
 
An Individuals Control Chart for the same SNR values charted in Figure 4.5.1-4 is shown 
in Figure 4.5.1-5.  The lower 0.001 control limit was calculated to be 127.1 based on the 
summary statistics of the SNR values ( µˆ  = 590.28 and σˆ  = 149.4).  The lower 0.001 
control limit was calculated by assuming normality (e.g. limit = µˆ  – 3.1σˆ ).   
 
Figure 4.5.1-5: Individuals Chart for Tank V-211 SNR Values in 2001 
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All SNR values were above the one-sided lower control limit indicating that the process 
is in control.  Values ranged from 319 to 929.  The limit in this chart is smaller than the 
limit in the SNR chart, indicating less sensitivity to out of control signals. 
 
The chart below (Figure 4.5.1-6) is an individuals MR(2) chart for the SNR values with 
control limits based on +/- 3 σ limits of the range between two consecutive values.  All 
MR(2) values plotted within the control limits indicating that the process is in control.   
 
Figure 4.5.1-6: MR(2) Chart for Tank V-211 SNR Values in 2001 
MR(2) Chart for v211bmey01snrn
0 5 10 15 20 25
Observation
0
100
200
300
400
500
M
R
(2
)
CTR = 149.
UCL = 487.
LCL = 0.
 
 
In order to compare the performance of the SNR and individuals charts, the plot below 
(Figure 4.5.1-7) shows Operating Characteristic (OC) curves for the SNR and individuals 
control charts shown in Figures 4.5.1-4 and 4.5.1-5.  The curves estimate the probability 
of the SNR values plotting outside the control limits for a given value of δ. 
 
Figure 4.5.1-7:  OC Curves for SNR and Individuals Charts for Tank V-211 (N=10) 
OC Curves for SNR and Individuals Charts for 
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The data resulted in a non-centrality parameter of 554.2 and a 0.001 critical value of 
314.9 (9 degrees of freedom).   
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Based on a review of the chart above, the SNR Chart OC Curve displays superior 
performance to the Individuals Chart OC Curve.  For smaller values of δ, the SNR chart 
has a much higher probability of detecting out of control data points.  The Individuals 
Chart has an extremely low probability (near 0) of detecting an out of control signal for δ 
values as low as 200.  In contrast, the SNR chart has an extremely high probability (near 
1) of detecting an out of control signal for δ values as low as 200.   
 
4.5.2. Tank V-212 
 
Begin, middle, and end data from the first 25 batches manufactured during the year 2001 
for Line #2 (Tank V-212) were analyzed.  For each group of 10 content uniformity values 
from a single batch, the quantity ( n x  / s) was calculated.  The summary statistics for 
the quantity ( n x  / s) are detailed below: 
 
Table 4.5.2-1:  Summary Statistics – Tank V-212 SNR Values in 2001 
 
Summary Statistics for v212bmey01snrn
Count = 25
Average = 442.019
Median = 446.877
Mode = 
Geometric mean = 428.717
Variance = 12364.0
Standard deviation = 111.194
Standard error = 22.2387
Minimum = 275.338
Maximum = 701.081
Range = 425.743
Lower quartile = 375.703
Upper quartile = 510.089
Interquartile range = 134.386
Skewness = 0.455695
Stnd. skewness = 0.930184
Kurtosis = 0.103541
Stnd. kurtosis = 0.105676
Coeff. of variation = 25.1559%
Sum = 11050.5  
 
 
 
Percentiles for v212bmey01snrn
1.0% = 275.338
5.0% = 297.601
10.0% = 298.364
25.0% = 375.703
50.0% = 446.877
75.0% = 510.089
90.0% = 556.276
95.0% = 666.406
99.0% = 701.081  
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Figure 4.5.2-1: Box and Whisker Plot for Tank V-212 SNR Values in 2001 
Box-and-Whisker Plot
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Figure 4.5.2-2: Histogram for Tank V-212 SNR Values in 2001 
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Figure 4.5.2-3: Normal Probability Plot for Tank V-212 SNR Values in 2001 
Normal Probability Plot for v212bmey01snrn
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The normal probability plot of the data below indicates non-normality (as expected). 
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Delta3 was used to calculate the 0.001 critical value (δ = 415.6, 9 degrees of freedom) of 
236.1 for the control charts for these data.  
 
The SNR chart in Figure 4.5.1-4 plots the quantity n x  / s from the begin, middle, and 
end data from the first 25 batches manufactured during the year 2001 for Line #2 (Tank 
V-212): 
Figure 4.5.2-4: SNR Chart for Tank V-212 SNR Values in 2001 
X Chart for V212bmey01snrn
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All n x  / s values were above the one-sided lower control limit (level 0.001 critical 
value = 236.1) indicating that the process appears to be in control.  Values ranged from 
275 to 701.   
 
An Individuals Control Chart for the same SNR values charted in Figure 4.5.2-4 is shown 
in Figure 4.5.2-5.  The lower 0.001 control limit was calculated to be 97.3 based on the 
summary statistics of the SNR values.  The lower 0.001 control limit was calculated by 
assuming normality (e.g. limit = µˆ  – 3.1σˆ ). 
Figure 4.5.2-5: Individuals Chart for Tank V-212 SNR Values in 2001 
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All n x  / s values were above the one-sided lower control limit (level 0.001 critical 
value = 97.3) indicating that the process appears to be in control.  Values ranged from 
275 to 701.  The limit in this chart is smaller than the limit in the SNR chart, indicating 
less sensitivity to out of control signals. 
 
The chart below is an individuals MR(2) chart with control limits based on +/- 3 σ limits 
of the range between two consecutive values.  All MR(2) values plotted within the 
control limits indicating that the process is in control.   
 
Figure 4.5.2-6: MR(2) Chart for Tank V-212 SNR Values in 2001 
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In order to compare the performance of the SNR and individuals charts, the plot below 
(Figure 4.5.2-7) shows Operating Characteristic (OC) curves for the SNR and individuals 
control charts shown in Figures 4.5.2-4 and 4.5.2-5.  The curves estimate the probability 
of the SNR values plotting outside the control limits for a given value of δ. 
 
Figure 4.5.2-7:  OC Curves for SNR and Individuals Charts for Tank V-211 (N=10) 
OC Curves for SNR and Individuals Charts for Tank V-
212 (N = 10)
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The data resulted in a non-centrality parameter of 415.6 and a 0.001 critical value of 
236.1 (9 degrees of freedom).  This point is plotted on the chart and indicates that there is 
a 0.001 probability of the process (with a non-centrality parameter of 415.6) plotting 
below the control limit. 
 
Based on a review of the chart above, the SNR Chart OC Curve displays superior 
performance to the Individuals Chart OC Curve.  For smaller values of δ, the SNR chart 
has a much higher probability of detecting out of control data points.  The Individuals 
Chart has an extremely low probability (near 0) of detecting an out of control signal for δ 
values as low as 150.  In contrast, the SNR chart has an extremely high probability (near 
1) of detecting an out of control signal for δ values as low as 150.  
 
4.6. Performance of the SNR Chart  
 
4.6.1. Comparison of the SNR Chart to the Individuals Chart 
 
Recall Figure 4.5.1-7 which shows the OC curves for the SNR and individuals control 
charts based on the Tank V-211 data.  The chart indicates that the SNR Chart is superior 
to the Individuals Chart.  
 
4.6.2. Performance of the SNR Chart (N=10 vs N=5) 
 
To further explore the performance of the SNR chart, OC curves were computed for SNR 
data from samples of size 5.  Figure 4.6-1 shows the comparison of the SNR Chart for 
samples sizes of 5 and 10. As expected, the SNR Chart with N=10 displays superior 
performance to the SNR Chart (N = 5). 
 
Figure 4.6.2-1:  OC Curves for SNR Charts for Tank V-211 (N=10 vs N=5) 
OC Curves for SNR Charts for Tank V-211
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4.6.3. SNR Chart Performance In Terms of The Non-centrality Parameter 
 
To further explore the performance of the SNR chart, OC curves were computed for 
SNR.  The control limits for an SNR chart are computed from the non-central t 
distribution with given values of degrees of freedom and non-centrality parameter. We 
will denote this “null” value of the non-centrality parameter by δ0.  To explore the 
performance of the SNR chart as δ0 varies, we created OC curves for level 0.001 charts 
with 9 degrees of freedom and non-centrality parameters δ based on different 0δ values 
using the formula.  
 
δ = δ0 + k*std(δ0), (6) 
 
  where, 
δ0 = initial value of δ based on real data 
k = constant varying over (-1.0,0.2) by 0.1 increments 
std(δ0) = standard deviation of δ0 based on (2)  
 
The curves in the chart in Figure 4.6-2 were based on computations for different values of 
δ.  For a particular value of δ and a sample size of 10, a 0.001 critical value was 
determined based on the non-central t distribution.  Then, equation (6) was used to 
determine which multiples of the subject value of δ would be plotted in the chart.  For the 
new values of δ, the corresponding probability of a value falling below the 0.001 critical 
value was calculated and these points were plotted on the chart.  This procedure was 
repeated for the different values of δ.   
 
Based on a review of the chart below, the OC curves corresponding to higher values of δ0 
display clearly superior performance up to δ0  values of 50 or so.  Once the δ0 values 
exceed 50 however, the effect appears to peak and larger values of δ0 do not improve 
performance. 
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Figure 4.6.3-1:  OC Curves for SNR Chart for Tank V-211 (N=10) 
OC Curves for SNR Chart for Tank V-211 (N = 10)
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Figure 4.6.3-2:  OC Curves for SNR Chart for Tank V-211 (N=5) 
OC Curves for SNR Chart for Tank V-211 (N = 5)
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The same procedures as described above were used to create the chart in Figure 4.6-3, 
except that the sample size of 5 was used. 
 
Although both charts indicate that higher values of δ  display superior performance up to 
a certain point, the difference in performance between the different values of δ is smaller 
for the N = 5 case, as compared to the N = 10 case. 
 
 
 36
 
5. Conclusion 
 
The objective of this project was to study the content uniformity assay values for the 0.25 
mg/mL (0.5 mg) manufacturing process through the application of statistical techniques.  
The study focused on three separate tasks: (1)  Monitoring process behavior for content 
uniformity assay values, (2)  Ascertaining the equivalence of batches manufactured on 
Line 1 vs Line 2,  and (3)  Monitoring the signal to noise ratio of the content uniformity 
assay values 
 
In order to accomplish the three tasks above, the following statistical techniques were 
applied:  (1)  Control chart techniques were applied to the data, including standard 
control chart techniques ( x  and S), individuals control chart techniques, and modified 
limits, (2) An equivalence test for the means of the two processes was conducted, and (3) 
A new control chart, the SNR chart, was developed and implemented  
 
The traditional statistical process control techniques ( x  and S) that were applied in 
Section 2 resulted in the determination that the process was not in statistical process 
control.  One reason for the process not being in statistical control is the potential for 
mixing to occur during the sampling process.  The patterns that are shown on the x  
charts may be symptomatic of mixing.  Since there are 10 independent filling needles on 
the Blow-Fill-Seal Machine and samples of 4 (begin), 3 (middle), and 3 (end) are 
randomly collected for each batch, the performance of a specific filling needle is not 
being consistently represented.  This phenomenon could be a subject for future study.  
Unfortunately, this issue could not be addressed appropriately in this document since the 
author did not have ownership of the process. 
 
The fact that between-batch variation was large relative to within-batch variation, and 
that the units were filled on multiple nozzles suggested that mixing was at least partly to 
blame for the poor patterns observed on the x charts.  Since there was no record of which 
nozzles filled which of the tested units, a more appropriate method was sought for 
charting the process level.  By eliminating within-batch variation as the measure of the 
size of between-batch variation, Individual Measurement Control Charts provide an 
alternative, and perhaps, fairer measure of process control.  The charts were created by 
treating each batch as a single observation (e.g. the content uniformity values from begin, 
middle, and end portions of each batch were averaged to obtain one data point).  The 
control procedure uses the moving range of two successive observations to estimate the 
process variability.  This technique also resulted in the conclusion that the process was 
not in statistical process control, but was quite close to being so.   
 
Despite the fact that traditional x  and S control charts and Individual Measurement 
control charts indicated that the Line 1 and 2 processes in 2001 were not in statistical 
control, the natural variability of the processes was much smaller than the range of the 
specification limits. 0.237 – 0.262 mg/mL.  In such situations, Modified Control Charts 
are appropriate for process monitoring if some drift in the process mean is acceptable.  
The modified x  control chart is concerned only with detecting whether the true process 
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mean µ is located such that the process is producing a fraction non-conforming in excess 
of some specified value δ.  This approach resulted in the conclusion that the process was 
in statistical process control with respect to the modified limits.   
 
The equivalence test that was developed in Section 3 was a practical method to determine 
if the finished product results from the subject lines were equivalent.  Prior to conducting 
this analysis, the process was verified to be in statistical process control with respect to 
the modified control limits.  Based on the equivalence method outlined, the Line 1 and 2 
content uniformity data from 2001 were statistically equivalent.   
 
In order to chart and determine whether or not the SNR values were in statistical process 
control, a new chart (SNR) was developed.  The SNR Chart was based on the assumption 
that the quantity ( n x  / s) was non-central t distributed.  Based on this assumption, a 
lower one-sided control limit was calculated.  Review of the SNR charts for both 
compounding tanks revealed that all n x  / s values were above the one-sided lower 
control limit indicating that the processes were in statistical control.   
 
The non-central t distribution characterized the SNR values well.  Three different 
methods for estimating the non-centrality parameter δ were considered [using (1) SNRx  
(2) s2SNR (3) setting δ = s
nx  ].  In order to ascertain the best of these three estimation 
methods, a small simulation study was conducted and method 3 appeared to be most 
optimal.    
 
In order to compare the performance of the SNR Chart to the Individuals Chart, both 
theoretical calculations and Monte Carlo simulations using the SAS macro simulation 
(Appendix 1) were utilized.  The SNR control chart displayed superior performance to 
the Individuals control chart as it has a shorter response time to detect out of control 
signals.   
 
We looked at operating characteristic curves for two sample sizes: N = 10 and N = 5. 
Although in both cases, the SNR Chart was superior to the Individuals Chart, the 
difference in performance between the SNR and Individuals Charts appeared to be 
smaller for the N = 5 case, as compared to the N = 10 case.  As expected, the SNR Chart 
(N = 10) was superior to the SNR Chart (N = 5).   
 
Based on a review of the OC Curves for different values of δ0, higher values of δ0 appear 
to display superior performance, but the improvement in performance was negligible for 
δ0 values above 50. 
 
As a result of this study, a great deal has been learned about the process.  The process 
changes corresponding to these results have the potential to effect process improvements.   
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Appendix 1:  SAS macro (simulation) 
 
 
/* User specifies # of subsets, subset sample size */ 
 
%macro simulate(sigsize,noisize, sigsize1, noisize1); 
 
/* Creates a column of values (1 to noisize, sigsize times) */ 
 
data one; 
 %do i=1 %to &sigsize.; 
  %do j=1 %to &noisize.; 
   sample=&i.; 
  output; 
  %end; 
 %end; 
run; 
 
/* Creates a matrix (sigsize x noisize = R by 1002) by sample.  Generates a 1000 columns 
of R 
values by sample which are normally distributed with mean and sigma specified by the 
user. 
Generates a column of random z values. */ 
 
data one; 
 set one; 
 array y{1000} y1-y1000; 
 %do i=1 %to 1000; 
  z=rannor(-1); 
  y{&i.}=0*sample+0.248+.003*z; 
 %end; 
run; 
 
/* Creates a matrix (sigsize by 1003) by sample.  Generates 1000 columns of sigsize 
coefficent of variation values by sample. Generates a column of type and frequency. */ 
 
proc means data=one noprint; 
 var y1-y1000; 
 by sample; 
 output out = sumstat cv=cv1-cv1000; 
run; 
 
/* Creates a row of type, frequency, 1000 values of N, 1000 values of mean, and 1000 
values of std. */ 
 
proc means data=one noprint; 
 var y1-y1000; 
 output out = sumstat1 n=n1-n1000 mean=mean1-mean1000 std=std1-std1000; 
run; 
 
/* Creates a matrix (1000 x 5) of sample, N, Mean, STD, and Delta3 values. 
Delta3 is calculated with the following formuala: 
(((&noisize.)**(0.5))*mean) / std */ 
 
data signal3(keep=sample n mean std); 
  set sumstat1; 
  %do i=1 %to 1000; 
    sample=&i.; 
    n=n&i.; 
    mean=mean&i.; 
    std=std&i.; 
    output; 
  %end; 
run; 
 
data signal3; 
  set signal3; 
  delta3 = (((&noisize.)**(0.5))*mean) / std; 
run; 
 
/* Creates a row of type, frequency, mdelta3 = means of delta3 values. */ 
 
proc means data=signal3; 
 var delta3; 
 output out=del3 mean=mdelta3; 
 run; 
 
data _null_; 
 set del3; 
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  call symput('mdelta3',trim(left(put(mdelta3,best10.)))); 
run; 
 
proc print data=signal3; 
run; 
 
/* Creates a matrix (sigsize by 1001) by sample.  Generates 1000 columns of sigsize 
signal to noise ratio values by sample. */ 
 
data signal(drop=_TYPE_ _FREQ_); 
  set sumstat; 
  %do i = 1 %to 1000; 
    snr&i. = 100/ cv&i.; 
    drop cv&i.; 
  %end; 
run; 
 
/* Creates a row of type, frequency, 1000 values of N, 1000 values of mean, and 1000 
values of var. */ 
 
proc means data=signal noprint; 
  var snr1-snr1000; 
  output out=sumstat2 n=n1-n1000 mean=mean1-mean1000 var=var1-var1000; 
run; 
 
/* Creates a matrix (1000 x 8) of sample, N, MEAN, VAR, GOFF, GOFF2, DELTA1, 
and DELTA2 values.  GOFF, GOFF2, DELTA1, and DELTA2 are calculated with the 
following formualas: 
  goff = gamma((&noisize.-2)/2) / gamma((&noisize.-1)/2); 
  goff2 = goff**2; 
  delta1 = (((&noisize.)**(0.5))*mean) / ((((&noisize.-1)/2)**(0.5))*goff); 
  delta2 = ((((&noisize.)*var)-((&noisize.-1)/(&noisize.-3))) / 
(((&noisize.-1)/(&noisize.-3))*(1-(((&noisize.-3)/2)*goff2))))**(0.5) */ 
 
data signal2(keep=sample n mean var); 
  set sumstat2; 
  %do i=1 %to 1000; 
    sample=&i.; 
    n=n&i.; 
    mean=mean&i.; 
    var=var&i.; 
    output; 
  %end; 
run; 
 
data signal2; 
  set signal2; 
  goff = gamma((&noisize.-2)/2) / gamma((&noisize.-1)/2); 
  goff2 = goff**2; 
  delta1 = (((&noisize.)**(0.5))*mean) / ((((&noisize.-1)/2)**(0.5))*goff); 
  delta2 = ((((&noisize.)*var)-((&noisize.-1)/(&noisize.-3))) / 
(((&noisize.-1)/(&noisize.-3))*(1-(((&noisize.-3)/2)*goff2))))**(0.5); 
run; 
 
/* Creates a row of type, frequency, mdelta1 = means of delta1, and 
mdelta2 = means of delta2 values. */ 
 
proc means data=signal2; 
 var delta1 delta2; 
 output out=mdelta3 mean=mdelta1 mdelta2; 
run; 
 
data _null_; 
  set mdelta3; 
   call symput('mdelta1',trim(left(put(mdelta1,best10.)))); 
   call symput('mdelta2',trim(left(put(mdelta2,best10.)))); 
run; 
 
proc print data=signal2; 
run; 
 
/* Creates a matrix (sigsize by 1001) by sample.  Generates 1000 columns of sigsize 
signal to noise ratio values by sample which have been multiplied by the values: 
((&noisize.)**(0.5)). */ 
 
data signalc; 
  set signal; 
  %do i = 1 %to 1000; 
    snrc&i. = ((&noisize.)**(0.5))*snr&i.; 
    drop snr&i.; 
  %end; 
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run; 
 
/* Creates a row of type, frequency, and minimum values = to the minimum 
values of the 1000 columns of SNRC values. */ 
 
proc summary data=signalc print min; 
   var snrc1-snrc1000; 
   output out=minsum min=min1-min1000; 
run; 
 
/* Creates a row of X1, 1000 minimum values, and a sum.  The X1 term is equal 
to the 0.001 critical value of the non-central t distribution based on a 
non-centrality parameter = average of the delta1 values (mdelta1).  The critical 
value is compared to the minimum snrc value (SNR x n^0.5) and a 1 is returned if 
the minimum value is greater than the critical value.  The sum term is equal to 
the sums of the ones and zeros to be able to determine the # of minimums which 
were below the critical value.  This procedure is repeated for delta2 and delta3 
values. */ 
 
data compare1(drop=_TYPE_ _FREQ_ min1-min1000); 
  set minsum; 
   x1=tinv(.001,(&noisize.-1), &mdelta1); 
   %do i = 1 %to 1000; 
    c&i. = (min&i.>x1); 
   %end; 
run; 
 
data compare2(drop=_TYPE_ _FREQ_ min1-min1000); 
  set minsum; 
   x2=tinv(.001,(&noisize.-1), &mdelta2); 
   %do i = 1 %to 1000; 
    c&i. = (min&i.>x2); 
   %end; 
run; 
 
data compare3(drop=_TYPE_ _FREQ_ min1-min1000); 
  set minsum; 
   x3=tinv(.001,(&noisize.-1), &mdelta3); 
   %do i = 1 %to 1000; 
     c&i. = (min&i.>x3); 
   %end; 
run; 
 
data compare1; 
 set compare1; 
 sum=sum(of c1-c1000); 
run; 
 
data compare2; 
 set compare2; 
 sum=sum(of c1-c1000); 
run; 
 
data compare3; 
 set compare3; 
 sum=sum(of c1-c1000); 
run; 
 
/* NEW PART 1 */ 
 
/* Creates a column of values (1 to noisize1, sigsize1 times) */ 
 
data two; 
 %do i=1 %to &sigsize1.; 
  %do j=1 %to &noisize1.; 
   sample=&i.; 
  output; 
  %end; 
 %end; 
run; 
 
/* Creates a matrix (sigsize1 x noisize1 = R by 1002) by sample.  Generates a 1000 
columns of R 
values by sample which are normally distributed with mean and sigma specified by the 
user. 
Generates a column of random z values. */ 
 
data two; 
 set two; 
 array y{1000} y1-y1000; 
 %do i=1 %to 1000; 
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  z=rannor(-1); 
  y{&i.}=0*sample+0.248+.003*z; 
 %end; 
run; 
 
/* Creates a matrix (sigsize1 by 1003) by sample.  Generates 1000 columns of sigsize1 
coefficent of variation values by sample. Generates a column of type and frequency. */ 
 
proc means data=two noprint; 
 var y1-y1000; 
 by sample; 
 output out = sumstat3 cv=cv1-cv1000; 
run; 
 
data signal(keep=sample cval1-cval1000 low1-low1000); 
  set sumstat3; 
    %do i = 1 %to 1000; 
      snr&i. = 100 / cv&i.; 
      cval&i. = snr&i. * (&noisize.**.5); 
      low&i. = 0; 
      if cval&i. < 200 then low&i. = 1; 
    %end; 
run; 
 
data signal(keep=sample rlength cval); 
  set signal; 
  %do i = 1 %to 1000; 
      if low&i. = 1 then do; 
      rlength = &i.; 
      cval = cval&i.; 
      i = 1000; 
      output; 
      end; 
  %end; 
run; 
 
proc print; 
run; 
 
proc sort data=signal; 
  by sample rlength; 
run; 
 
proc print; 
run; 
 
data signal2; 
  set signal; 
  by sample rlength; 
  if first.sample; 
run; 
 
 
proc print; 
run; 
 
proc means data = signal2; 
  var rlength; 
  output out = sumstat4 mean=mean n=n std=std uclm=uclm lclm=lclm; 
run; 
 
%mend simulate; 
%simulate(25,10,50,10); 
 
 
%macro simulate(sigsize,noisize,inputmn,inputsd); 
 
data three; 
 %do i=1 %to &sigsize.; 
  %do j=1 %to &noisize.; 
   sample=&i.; 
  output; 
  %end; 
 %end; 
run; 
 
data three; 
 set three; 
 array y{1000} y1-y1000; 
 %do i=1 %to 1000; 
  z=rannor(-1); 
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  y{&i.}=0*sample+ &inputmn. + &inputsd.*z; 
 %end; 
run; 
 
/* Creates a matrix (sigsize by 1003) by sample.  Generates 1000 columns of 
sigsize 
coefficent of variation values by sample. Generates a column of type and 
frequency. */ 
 
proc means data=three noprint; 
 var y1-y1000; 
 by sample; 
 output out = sumstat5 cv=cv1-cv1000; 
run; 
 
data signal5(keep=sample cval1-cval1000 low1-low1000); 
  set sumstat5; 
    %do i = 1 %to 1000; 
      snr&i. = 100 / cv&i.; 
      cval&i. = snr&i. * (&noisize.**.5); 
      low&i. = 0; 
      if cval&i. < 200 then low&i. = 1; 
    %end; 
run; 
 
data signal5(keep=sample rlength cval); 
  set signal5; 
  %do i = 1 %to 1000; 
      if low&i. = 1 then do; 
      rlength = &i.; 
      cval = cval&i.; 
      i = 1000; 
      output; 
      end; 
  %end; 
run; 
 
proc sort data=signal5; 
  by sample rlength; 
run; 
 
data signal6; 
  set signal5; 
  by sample rlength; 
  if first.sample; 
run; 
 
proc means data = signal6; 
  var rlength; 
  output out = sumstat6 mean=mean n=n std=std uclm=uclm lclm=lclm; 
run; 
 
proc print; 
run; 
 
 
%mend simulate; 
%simulate(25,10,0.243,0.003); 
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Appendix 4a:  Results of the SAS Macro Simulation  
 
OBS    SAMPLE    RLENGTH      CVAL 
 
1       1        577      315.239 
2       2         84      297.696 
3       3        310      303.142 
4       4        128      314.280 
5       5        311      311.428 
6       6         98      298.315 
7       7        607      314.429 
8       8         32      303.638 
9       9        184      314.358 
10      10        313      295.903 
11      11        108      263.752 
12      12         59      258.182 
13      13        567      293.137 
14      14         36      294.070 
15      15        554      309.796 
16      16        244      302.268 
17      17         41      302.637 
18      18        158      302.823 
19      19        324      312.360 
20      20        114      311.173 
21      21        536      307.524 
22      22         36      294.123 
23      23        331      298.152 
24      24        418      302.742 
25      25        388      310.545 
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Appendix 4b:  Results of the SAS Macro Simulation 
 
 
OBS    SAMPLE    RLENGTH      CVAL 
 
1       1        538      312.320 
2       2        226      299.408 
3       3         77      314.086 
4       4        657      313.702 
5       5        118      291.494 
6       6         61      308.911 
7       7          9      305.978 
8       8         36      293.112 
9       9        321      308.216 
10      10        501      288.800 
11      11         49      310.281 
12      12        221      308.512 
13      13         36      287.262 
14      14        176      311.470 
15      15         82      298.419 
16      16         21      280.864 
17      17        140      310.850 
18      18        189      285.706 
19      19         54      297.879 
20      20         13      294.721 
21      21        191      298.382 
22      22        188      300.971 
23      23         80      306.944 
24      24         19      304.597 
25      25        122      281.537 
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Appendix 4c:  Results of the SAS Macro Simulation 
 
 
OBS    SAMPLE    RLENGTH      CVAL 
 
1       1         94      306.764 
2       2         52      305.806 
3       3         28      301.862 
4       4        110      312.290 
5       5         68      305.994 
6       6         70      290.817 
7       7          5      286.204 
8       8         94      297.611 
9       9         90      302.768 
10      10         29      312.318 
11      11        265      306.495 
12      12        111      313.896 
13      13        284      313.339 
14      14         53      310.468 
15      15         46      295.730 
16      16        130      294.269 
17      17         17      311.678 
18      18        157      240.423 
19      19         23      312.382 
20      20         12      311.799 
21      21         20      297.985 
22      22          5      306.719 
23      23         46      284.855 
24      24         21      295.019 
25      25        330      300.879 
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Appendix 4d:  Results of the SAS Macro Simulation (.15, .00154) 
 
 
OBS    SAMPLE    RLENGTH      CVAL 
 
1       1         10      180.880 
2       2         22      225.464 
3       3         23      213.579 
4       4          7      206.961 
5       5         21      206.137 
6       6         10      190.072 
7       7         16      205.700 
8       8         14      224.027 
9       9         49      215.243 
10      10          2      218.775 
11      11         68      204.320 
12      12         12      205.048 
13      13          1      225.524 
14      14          8      162.694 
15      15          7      170.905 
16      16          5      219.862 
17      17         18      222.593 
18      18          1      218.098 
19      19          8      223.262 
20      20         64      221.040 
21      21          3      208.550 
22      22         18      217.482 
23      23         16      225.510 
24      24          7      207.594 
25      25          6      203.791 
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Appendix 4e:  Results of the SAS Macro Simulation (.2465, .00252) - Individuals 
 
 
OBS    SAMPLE    RLENGTH      CVAL 
 
1       1          6      224.429 
2       2         16      211.386 
3       3         38      211.972 
4       4         10      225.774 
5       5         14      224.423 
6       6          6      214.853 
7       7          1      200.429 
8       8          4      208.209 
9       9         25      208.078 
10      10          7      220.246 
11      11          8      165.243 
12      12         53      205.592 
13      13         43      219.336 
14      14          2      211.440 
15      15         28      214.511 
16      16         27      206.586 
17      17          1      203.968 
18      18          3      215.003 
19      19         48      212.680 
20      20         49      213.759 
21      21         14      204.318 
22      22         50      216.616 
23      23         11      219.664 
24      24          8      208.055 
25      25         19      203.637 
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Appendix 4f:  Results of the SAS Macro Simulation (.2465, .00252) - SNR 
 
 
OBS    SAMPLE    RLENGTH      CVAL 
 
1       1         1       302.729 
2       2         1       314.335 
3       3         2       225.513 
4       4         2       310.738 
5       5         1       280.214 
6       6         1       221.630 
7       7         3       257.498 
8       8         1       310.422 
9       9         2       257.279 
10      10         1       313.199 
11      11         1       278.952 
12      12         2       303.364 
13      13         3       299.858 
14      14         2       238.105 
15      15         1       292.074 
16      16         1       252.944 
17      17         2       292.694 
18      18         1       307.353 
19      19         1       252.173 
20      20         1       288.266 
21      21         1       309.825 
22      22         5       288.109 
23      23         4       314.306 
24      24         1       295.453 
25      25         1       229.127 
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